· remissions and exacerbations occur
· disability not inevitable
· maintain realistic lifestyle
· drugs take weeks or months to work
General
· can alleviate acute flare of polyarthritis
· reduces joint pain and swelling
· admission may be warranted
Local
· splintage can rest joint flare-up
· maintain ROM
· daily movement through range
· minimise muscle wasting
· daily gentle exercises
· minimise deformity
· anatomical positioning
· eg. sleep positioning, no pillows under knees
· aims
· alleviate pain and swelling
· modify course of disease
· first-line therapy
· used in almost all cases
· alleviate pain and swelling
· do not modify course of disease
· side-effects troublesome
· skin rashes
· gastric ulceration
· renal dysfunction
· care if administering with
· warfarin
· peptic ulcer disease
· advancing age
· second-line therapy
· generally similar
· effective in 50-80%
· improve symptoms and signs in short and medium term
· some slowing of progress of disease
· toxicity is problem
Indications
· clinical evidence of synovitis
· inadequate response to NSAIDs
· erosive disease on x-ray
Types
Gold salts
· inhibit monocyte function
· intramuscular route
· oral less toxic but less effective
· need close monitoring
· toxicity in 30-40%
· dermatitis, mouth ulcers, pruritis (most common)
· thrombocytopaenia
· neutropaenia
· proteinuria
· screening
· FBC and urinalysis
Penicillamine
· modulates lymphocyte function
· toxicity in 50%
· similar profile to gold
Antimalarials
· chloroquine and hydroxycholoroquine
· stabilise lysosomal membranes and inhibit IL-1 function
· less life-threatening toxicity
· major side-effect is macular degeneration
· screening
· ocular examination
Sulphasalazine
· anti-folate activity
· less serious side-effects
· GIT upset
· headache
Immunosuppressants and cytotoxics
· includes
· methotrexate
· azathioprine
· cyclophosphamide
· high incidence of toxicity
· dose-related marrow suppression
· susceptibility to infection
· GI intolerance
· increased risk of malignancy
· infertility
· teratogenesis
Oral
· dramatically effective
· long-term side-effects
· osteoporosis
· hypertension
· diabetes
· indications
· refractory disease (where other treatments have failed)
· as interim therapy (while waiting for disease-modifying drugs to work)
· severe nonarticular manifestations of rheumatoid disease
· operative complications
· impaired wound healing
· increased risk of infection
· post-operative hypotension
· wound dehiscence
· cover required
· replacement of oral dose with intravenous hydrocortisone required with premedication and while unable to take oral dose
· increased dose with infection
Intra-articular
· sepsis rare with aseptic technique
· no more often than three-monthly